Author

Terri J. Warren

Observed names: T Warren, T. Warren, TERRI J. WARREN, Terri Warren

Observed institutions: National Institutes of Health, University of Washington, California State University, San Marcos, Fred Hutch Cancer Center, National Institute of Allergy and Infectious Diseases, National Cancer Institute, Westover Heights Clinic, National Institutes of Health Clinical Center, Division of Cancer Epidemiology and Genetics, Benaroya Research Institute

OpenAlex ID: A5113845809

Once-Daily Valacyclovir to Reduce the Risk of Transmission of Genital Herpes

2003 · Lawrence Corey, Anna Wald, et al. · New England Journal of Medicine · 720

PDF

Genital herpes

2007 · Rachna Gupta, Terri Warren, et al. · The Lancet · 595

Reactivation of Genital Herpes Simplex Virus Type 2 Infection in Asymptomatic Seropositive Persons

2000 · Anna Wald, Judith Zeh, et al. · New England Journal of Medicine · 580

Recombinant Glycoprotein Vaccine for the Prevention of Genital HSV-2 Infection

1999 · Lawrence Corey, Andria G. M. Langenberg, et al. · JAMA · 490

Helicase–Primase Inhibitor Pritelivir for HSV-2 Infection

2014 · Anna Wald, Lawrence Corey, et al. · New England Journal of Medicine · 174

Valacyclovir and Acyclovir for Suppression of Shedding of Herpes Simplex Virus in the Genital Tract

2004 · Rachna Gupta, Anna Wald, et al. · The Journal of Infectious Diseases · 174

Topical Resiquimod 0.01% Gel Decreases Herpes Simplex Virus Type 2 Genital Shedding: A Randomized, Controlled Trial

2007 · Karen E. Mark, Lawrence Corey, et al. · The Journal of Infectious Diseases · 110

Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences

2016 · Anna Wald, Burkhard Timmler, et al. · JAMA · 109

PDF

From the NIH: Proceedings of a Workshop on the Importance of Self-Obtained Vaginal Specimens for Detection of Sexually Transmitted Infections

2008 · Marcia M. Hobbs, Barbara van der Pol, et al. · Sexually Transmitted Diseases · 108

A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects

2005 · Guy de Bruyn, Mauricio Vargas-Cortez, et al. · Vaccine · 89

Valacyclovir for the Suppression of Recurrent Genital Herpes in Human Immunodeficiency Virus–Infected Subjects

2003 · Edwin DeJesus, Anna Wald, et al. · The Journal of Infectious Diseases · 89

Comparative Efficacy of Famciclovir and Valacyclovir for Suppression of Recurrent Genital Herpes and Viral Shedding

2006 · Anna Wald, Stacy Selke, et al. · Sexually Transmitted Diseases · 86

Genital Shedding of Herpes Simplex Virus among Men

2002 · Anna Wald, Judith Zeh, et al. · The Journal of Infectious Diseases · 83

Persistent Genital Herpes Simplex Virus-2 Shedding Years Following the First Clinical Episode

2010 · Warren Phipps, Misty Saracino, et al. · The Journal of Infectious Diseases · 82

PDF

Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons

2011 · Anna Wald, David M. Koelle, et al. · Vaccine · 80

Therapeutic Vaccine for Genital Herpes Simplex Virus-2 Infection: Findings From a Randomized Trial

2017 · David I. Bernstein, Anna Wald, et al. · The Journal of Infectious Diseases · 69

Association of Major Histocompatibility Complex Determinants with the Development of Symptomatic and Asymptomatic Genital Herpes Simplex Virus Type 2 Infections

1999 · Julie A. Lekstrom‐Himes, Patricia Hohman, et al. · The Journal of Infectious Diseases · 60

Once-Daily Valacyclovir to Reduce the Risk of Transmission of Genital Herpes

2004 · Lawrence Corey, Anna Wald, et al. · Obstetrical & Gynecological Survey · 52

APOE genotype is associated with oral herpetic lesions but not genital or oral herpes simplex virus shedding

2010 · D. M. Koelle, A. Magaret, et al. · Sexually Transmitted Infections · 51

Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital Herpes Simplex Virus-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled Trial

2018 · Nicholas Van Wagoner, Kenneth Fife, et al. · The Journal of Infectious Diseases · 49

PDF

Type-Specific Identification of Anogenital Herpes Simplex Virus Infections by Use of a Commercially Available Nucleic Acid Amplification Test

2012 · Barbara Van Der Pol, Terri Warren, et al. · Journal of Clinical Microbiology · 40

Famciclovir Reduces Viral Mucosal Shedding in HSV-Seropositive Persons

2007 · Peter Leone, Terri Warren, et al. · Sexually Transmitted Diseases · 33

Effect of Valacyclovir on Viral Shedding in Immunocompetent Patients With Recurrent Herpes Simplex Virus 2 Genital Herpes: A US-Based Randomized, Double-Blind, Placebo-Controlled Clinical Trial

2006 · Kenneth H. Fife, Terri J. Warren, et al. · Mayo Clinic Proceedings · 33

Performance of Commercial Enzyme-Linked Immunoassays for Diagnosis of Herpes Simplex Virus-1 and Herpes Simplex Virus-2 Infection in a Clinical Setting

2017 · Elfriede Agyemang, Quynh-An Le, et al. · Sexually Transmitted Diseases · 32

The ATPase Activity of Chaperonin GroEL Is Highly Stimulated at Elevated Temperatures

1996 · Jose A. Mendoza, Terri Warren, et al. · Biochemical and Biophysical Research Communications · 32

Works count: 50

Citation count: 4,275

H-index: 27

I10-index: 34